Sunday, 2 October 2016

INDIA TO SOON HAVE SEPARATE PHARMACEUTICALS MINISTRY: UNION MINISTER ANANTH KUMAR


"I have requested our Prime Minister Modiji to have an umbrella ministry for the pharma industry. We are hoping that it will be in place in sometime," said Union Minister Ananth Kumar.

Soon India will have a separate ministry for pharmaceuticals which will specifically deal with the issues pertaining to the pharma industry. "I have requested our Prime Minister Modiji to have an umbrella ministry for the pharma industry. We are hoping that it will be in place in sometime.
"It is a sunrise industry and needs to be set up fast," Union minister for chemicals and fertilisers Ananth Kumar said. He was speaking at the second edition of Mail Today's Health Conclave. Kumar, who recently attended the BRICS wellness workshop, raised the issue of integrated medicine at the seminar. Emphasising on 3As - authenticity, affordability and availability of medicines - he said that as per the rough estimate, nearly 50 per cent of the Indian population is not consuming 50 per cent of the consumption value.
Talking about the government's Jan Aushadi Yojana, he said that more than 400 outlets across the country have been set up so far and by the end of the year the country will have around 3,000 such centres that provide generic medicines to the poor patients at almost 40-50 per cent of the market price.
"Such centres will reduce the burden by 60 per cent. It is a great step towards improving the healthcare system," Kumar said.
PRADHAN MANTRI JAN AUSHADHI YOJANA
A countrywide campaign, for ensuring availability of generic medicines at affordable prices for all, under the project title Pradhan Mantri Jan Aushadhi Yojana (PMJAY) was initiated by the department of pharmaceuticals in association with central pharma public sector undertakings. It envisages key initiative of opening of dedicated outlets - Pradhan Mantri Jan Aushadhi Kendras (PMJAK) - where high-quality generic medicines are sold at low prices. Bureau of Pharma PSUs of India (BPPI) is implementing the scheme.
India has almost 10,000 pharma companies which are producing one lakh pharma formulation. The government has set up a pharma data bank in which the companies will have to register and give all the details. "About 63,000 formulations have been registered in the last two years. Pharma parks are being set up and many more will come up in the respective states of the country," he added.
CARDIAC STENT UNDER DRUG PRICE CONTROL DEPARTMENT
In an interesting move, the government has decided to bring cardiac stent under the drug price control department. According to the experts, the cost of the stent varies and it goes up to Rs 2.5 lakh. "We are going to regulate the price of cardiac stent to make them affordable for the common man. Patients are charged up to Rs 2.5 lakh," said Kumar.He cited a survey which showed that 90 per cent of the senior citizens at least take one medicine per day and almost 60 per cent of them take two to three medicines every day.
Talking about the importance of regulatory framework for affordable healthcare, he said that the "Modi's government policies are forwardlooking and caring".
"We want to be forwardlooking in terms of the quality. At the same time, we will be providing affordable medicines to the patients," he added.
For more updates follow srinivasulutirumalasetty.blogspot.com

Thank you for visiting my blog , Visit again for latest pharma updates

No comments:

Post a Comment